Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review ; volume:16 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-5 ; date:12.2018
Hereditary cancer in clinical practice ; 16, Heft 1 (27.4.2018), 1-5, 12.2018
- Urheber
-
Sæther, Nikolai Havn
- Beteiligte Personen und Organisationen
-
Skuja, Elina
Irmejs, Arvids
Maksimenko, Jelena
Miklasevics, Edvins
Purkalne, Gunta
Gardovskis, Janis
SpringerLink (Online service)
- DOI
-
10.1186/s13053-018-0092-2
- URN
-
urn:nbn:de:101:1-2018070115334677829604
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sæther, Nikolai Havn
- Skuja, Elina
- Irmejs, Arvids
- Maksimenko, Jelena
- Miklasevics, Edvins
- Purkalne, Gunta
- Gardovskis, Janis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma